News
Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second ...
Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track ...
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
wealth transfers will continue to increase. Generational wealth, typically passed down along family lines, may not represent a sea change in class structure but rather a shift in priorities and ...
The chart below compares the cost of an annualized semaglutide dosage from Hims, versus competitors: The pivot to liraglutide will allow Hims & Hers to prolong its operations in the weight-loss ...
"New York City Comptroller Brad Lander announced that he was increasing demands on asset managers for the city’s pension system – collectively the fourth largest public pension plan in the U.S. – to ...
BioPharmaDive notes that the pill Novo wants FDA approval for contains 70 times as much semaglutide as injectable Ozempic. The journal points out that such a large increase in dosage will require ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results